Maravai Lifesciences Holdings (MRVI) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$0.18.
- Maravai Lifesciences Holdings' EPS (Weighted Average and Diluted) rose 7352.94% to -$0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.84, marking a year-over-year increase of 4878.05%. This contributed to the annual value of -$1.88 for FY2024, which is 10917.79% down from last year.
- Per Maravai Lifesciences Holdings' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.18 for Q3 2025, which was up 7352.94% from -$0.27 recorded in Q2 2025.
- In the past 5 years, Maravai Lifesciences Holdings' EPS (Weighted Average and Diluted) ranged from a high of $0.53 in Q2 2022 and a low of -$0.8 during Q4 2023
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.05 (2023), whereas its average is $0.02.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first skyrocketed by 764781.23% in 2021, then tumbled by 126000.0% in 2024.
- Over the past 5 years, Maravai Lifesciences Holdings' EPS (Weighted Average and Diluted) (Quarter) stood at $0.43 in 2021, then plummeted by 30.23% to $0.3 in 2022, then plummeted by 366.67% to -$0.8 in 2023, then surged by 58.24% to -$0.33 in 2024, then soared by 46.12% to -$0.18 in 2025.
- Its last three reported values are -$0.18 in Q3 2025, -$0.27 for Q2 2025, and -$0.37 during Q1 2025.